San Francisco, CA, United States of America

Tom M Lam

USPTO Granted Patents = 7 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2020)
  • San Francisco, CA (US) (2019 - 2023)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
7 patents (USPTO):

Title: The Innovative Contributions of Tom M Lam

Introduction

Tom M Lam is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of Janus kinase (JAK) inhibitors. With a total of 7 patents to his name, Lam's work has the potential to impact the treatment of various inflammatory and fibrotic diseases.

Latest Patents

Among his latest patents, Lam has developed imidazolo indazole compounds as JAK inhibitors. These compounds, along with their pharmaceutically-acceptable salts, are designed to inhibit Janus kinases, which play a crucial role in inflammatory responses. Additionally, he has worked on fused pyrimidine pyridinone compounds as JAK inhibitors, specifically targeting JAK3. These compounds are also intended for use in treating gastrointestinal inflammatory diseases.

Career Highlights

Tom M Lam is currently associated with Theravance Biopharma R&D IP, LLC, where he continues to innovate in the pharmaceutical sector. His research focuses on creating effective treatments for diseases that currently have limited therapeutic options. Lam's dedication to advancing medical science is evident in his extensive patent portfolio.

Collaborations

Lam collaborates with notable colleagues, including Robert Murray McKinnell and Erik Fenster. These partnerships enhance the research and development efforts at Theravance Biopharma, fostering an environment of innovation and discovery.

Conclusion

Tom M Lam's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving healthcare. His work in developing JAK inhibitors is paving the way for new treatments for inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…